EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Different actions of deferoxamine and iron on gallium 67 abscess detection in rats


Journal of Nuclear Medicine 25(6): 668-672
Different actions of deferoxamine and iron on gallium 67 abscess detection in rats
The contrast-enhancing properties of Fe and deferoxamine (DFO) in abscess imaging with 67Ga citrate were compared in rats bearing turpentine-induced abscesses. Iron administration shifted 67Ga from plasma into tissues such as muscle and fat. As a result, the abscess-to-plasma ratio increased whereas the abscess-to-muscle ratio decreased. DFO enhanced the abscess-to-muscle and abscess-to-plasma ratios by increasing urinary 67Ga excretion. In contrast to Fe, DFO removed abscess-bound 67Ga, thus representing a disadvantage of DFO compared with Fe. As a result, the abscess-to-plasma ratio was more effecively enhanced by Fe than by DFO. Abscess imaging with 67Ga citrate may be improved by administration of Fe for detection of abscesses masked by blood activity, or DFO for detection of abscesses surrounded by muscle tissue.


Accession: 005151830



Related references

Different actions of deferoxamine and iron on Ga-67 abscess detection in rats. Journal of Nuclear Medicine 25(6): 668-672, 1984

Deferoxamine a promising bi functional chelating agent for labeling proteins with gallium gallium 67 labeled deferoxamine human serum albumin concise communication. Journal of Nuclear Medicine 23(10): 909-914, 1982

Effects of deferoxamine mesylate on gallium 67 distribution in normal and abscess bearing animals. Journal of Nuclear Medicine 21(5): 421-425, 1980

Re: "Protective Role of Silymarin and Deferoxamine against Iron Dextran-Induced Renal Iron Deposition in Male Rats," and "Co-Administration of Silymarin and Deferoxamine against Kidney, Liver and Heart Iron Deposition in Male Iron Overload Rat Model". International Journal of Preventive Medicine 5(6): 800-801, 2014

The effects of deferoxamine mesylate on gallium-67 distribution in normal and abscess-bearing animals: concise communication. Journal of Nuclear Medicine 21(5): 421-425, 1980

Comparative iron mobilizing actions of deferoxamine, 1,2-dimethyl-3-hydroxypyrid-4-one, and pyridoxal isonicotinoyl hydrazone in iron hydroxamate-loaded mice. Research Communications in Chemical Pathology and Pharmacology 73(3): 299-313, 1991

The gallium-deferoxamine complex: stability with different deferoxamine concentrations and incubation conditions. Applied Radiation and Isotopes 49(12): 1477-1479, 1998

Rapid excretion of gallium-67 isotope in an iron-overloaded patient receiving high-dose intravenous deferoxamine. American Journal of Hematology 29(4): 230-232, 1988

Deferoxamine an excellent bi functional chelating agent for labeling proteins with gallium gallium 67 labeled human serum albumin. Journal of Nuclear Medicine 22(6): P32-P33, 1981

Exploring the "iron shuttle" hypothesis in chelation therapy: effects of combined deferoxamine and deferiprone treatment in hypertransfused rats with labeled iron stores and in iron-loaded rat heart cells in culture. Journal of Laboratory and Clinical Medicine 138(2): 130-138, 2001